Form 8-K - Current report:
SEC Accession No. 0001140361-22-032942
Filing Date
2022-09-09
Accepted
2022-09-09 17:17:23
Documents
12
Period of Report
2022-09-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20004078x27_8k.htm   iXBRL 8-K 28630
  Complete submission text file 0001140361-22-032942.txt   163058

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA neog-20220902.xsd EX-101.SCH 3859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20220902_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20220902_pre.xml EX-101.PRE 16040
6 EXTRACTED XBRL INSTANCE DOCUMENT ny20004078x27_8k_htm.xml XML 4052
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 221236879
SIC: 2835 In Vitro & In Vivo Diagnostic Substances